News
Amarisoft and Dali Wireless Collaborate to Deliver Open RAN Based 4G and 5G Solutions
Interoperability and co-marketing initiatives will bring new options for enterprises, and mobile network operators deploying in-building cellular solutions Menlo Park, California and Paris, France – February 11, 2020 – Dali Wireless, a global leader in wireless fronthaul innovation for virtual RAN, and Amarisoft, a pioneer in software centric 4G LTE
Read More
ProterixBio licenses COVID-19 serology test from Massachusetts General Hospital
Billerica, MA, July 1, 2020: ProterixBio, Inc. today announced completing a licensing agreement with the Massachusetts General Hospital for a COVID-19 serology assay. The assay was developed and validated by researchers at the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University which is a joint
Read More
Oppilan Pharma Announces Positive Phase 1 Data for its Ulcerative Colitis Drug OPL-002 at Digestive Disease Week 2020 Virtual Scientific Program
Potential best-in-class profile for an oral sphingosine-1-phosphate receptor modulator – Dose-dependent reduction in circulating lymphocytes –– Rapid lymphocyte recovery after cessation of dosing –– Phase 2 study in ulcerative colitis patients in 4Q 2020 – ENCINITAS, California and Cambridge, United Kingdom, June 23, 2020 – Oppilan Pharma, Ltd., a clinical-stage
Read More
Zoll TherOx Receives CE Mark Approval for Supersaturated Oxygen Therapy
View Full Press Release >>
Read MoreFDA Approves Next-Generation ZOLL® TherOx System for Widowmaker Heart Attack Patients First
View Full Press Release >>
Read More
Perceptimed Founder Jacobs To Speak At Bio2device Group Event
PERCEPTIMED FOUNDER JACOBS TO SPEAK AT BIO2DEVICE GROUP EVENT MOUNTAIN VIEW, CA – April 25, 2014 – “Preventing Drug-Related Patient Injury and Death with Advanced, Cost-Effective Technology” is the topic Alan Jacobs, M.D., Ph.D., CEO and founder of PerceptiMed, will address at the Bio2Device lecture. The lecture will take place
Read MorePerceptimed Awarded NIH Development Grant
PERCEPTIMED AWARDED $1.5M NIH DEVELOPMENT GRANT MOUNTAIN VIEW, CA – PerceptiMed, Inc., was awarded a $1.5 million grant from the National Institutes of Health (NIH) to develop and test a secure, individual medication system for long-term care facilities. Dr. Alan Jacobs, CEO and founder of PerceptiMed will serve as
Read MoreScripps La Jolla First In U.S. To Use ZOLL’s FDA-Approved SuperSaturated Oxygen Therapy On Patients Suffering from Widowmaker Heart Attacks
View Full Press Release >>
Read More
NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA study in NASH and to Advance Two Additional SEFAs into the Clinic
Two new US investors; lead investor, venBio Partners and Sofinnova Investments, join syndicate of existing investors Richard Gaster, M.D., Ph.D., Principal at venBio Partners, and Maha Katabi, Ph.D., CFA, Partner at Sofinnova Investments join the Board Proceeds will be used to progress the SEFA development pipeline: Completion of Phase 2b
Read More
2019: A Look Back
2019 was an exciting and busy year for us! As we take a look back at some of our milestones, we’d like to give a big thank you to all of our publishers. We’re looking forward to what’s in store in the coming year! We’re happy to report that 2019
Read More
EXTEN Technologies and AIC to Provide NVMe-oF Storage Solutions Optimized for Supercomputing
AIC Shark Ultra-High-Performance Storage Target Delivers 80GB/S of Random IOPs in 2U with EXTEN NVMe-oF HyperDynamic Software Austin, November 14, 2019 – AIC and EXTEN® Technologies have partnered to provide a dense and scalable, software-defined NVMe-oF solution with record-breaking performance, advanced management, provisioning, and RAID data protection services. This disaggregated
Read MoreFor Digital Publishers, GTxcel’s New Content Hub is a Potential Game Changer
Faced with a growing ecosystem of platforms and distribution channels, digital publishers rely on more sophisticated tools to effectively deliver content and maintain their brand cohesiveness. If you’re like most digital publishers, you probably maintain a network of content distribution channels. Your digital edition, branded website, blog, video channel, and
Read More